Xuebo Pan

1.3k total citations
26 papers, 1.1k citations indexed

About

Xuebo Pan is a scholar working on Molecular Biology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Xuebo Pan has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Epidemiology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Xuebo Pan's work include Fibroblast Growth Factor Research (13 papers), Epigenetics and DNA Methylation (7 papers) and Kruppel-like factors research (7 papers). Xuebo Pan is often cited by papers focused on Fibroblast Growth Factor Research (13 papers), Epigenetics and DNA Methylation (7 papers) and Kruppel-like factors research (7 papers). Xuebo Pan collaborates with scholars based in China, Hong Kong and South Korea. Xuebo Pan's co-authors include Xiaokun Li, Zhuofeng Lin, Aimin Xu, Leigang Jin, Fan Wu, Yu Wang, Yi Zhang, Tingting Lü, Shaoqiang Lin and Fan Wu and has published in prestigious journals such as Circulation, Nature Communications and PLoS ONE.

In The Last Decade

Xuebo Pan

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuebo Pan China 15 638 287 170 155 105 26 1.1k
Carlos M. Rodríguez‐Ortigosa Spain 18 382 0.6× 264 0.9× 181 1.1× 234 1.5× 93 0.9× 37 1.1k
Misaki Iwashita Japan 18 398 0.6× 251 0.9× 184 1.1× 119 0.8× 136 1.3× 37 861
Ute Haas Germany 19 398 0.6× 380 1.3× 121 0.7× 132 0.9× 125 1.2× 36 1.1k
Zhengzhe Li China 19 471 0.7× 160 0.6× 77 0.5× 97 0.6× 155 1.5× 33 1.1k
Yiwen Li China 14 413 0.6× 136 0.5× 158 0.9× 128 0.8× 61 0.6× 48 839
Hailing Li China 16 336 0.5× 206 0.7× 167 1.0× 86 0.6× 101 1.0× 56 907
Zhen Sun China 17 319 0.5× 170 0.6× 119 0.7× 101 0.7× 184 1.8× 41 812
Xiaogang Du China 16 245 0.4× 203 0.7× 88 0.5× 123 0.8× 122 1.2× 44 791
Dhanunjay Mukhi United States 16 371 0.6× 138 0.5× 94 0.6× 89 0.6× 88 0.8× 27 853
Hélène L. Kammoun Australia 16 505 0.8× 645 2.2× 283 1.7× 340 2.2× 128 1.2× 24 1.4k

Countries citing papers authored by Xuebo Pan

Since Specialization
Citations

This map shows the geographic impact of Xuebo Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuebo Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuebo Pan more than expected).

Fields of papers citing papers by Xuebo Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuebo Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuebo Pan. The network helps show where Xuebo Pan may publish in the future.

Co-authorship network of co-authors of Xuebo Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Xuebo Pan. A scholar is included among the top collaborators of Xuebo Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuebo Pan. Xuebo Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Wen‐Juan, Guiyun Wang, Ye Wang, et al.. (2025). Sacubitril/Valsartan partially alleviates myocardial infarction injury by activating the FGF21 signaling pathway via PPARs. Cardiovascular Diabetology. 24(1). 89–89.
2.
Qiu, Feng, Wenshu Zhang, Jiale Chen, et al.. (2024). Fibroblast growth factor 21 alleviates acetaminophen induced acute liver injury by activating Sirt1 mediated autophagy. Cellular Signalling. 123. 111379–111379. 1 indexed citations
3.
Lin, Hui, Liuhong Shi, Jiale Chen, et al.. (2024). FGFR1 governs iron homeostasis via regulating intracellular protein degradation pathways of IRP2 in prostate cancer cells. Communications Biology. 7(1). 1011–1011. 2 indexed citations
4.
5.
Wu, Yu‐Yu, Ke Zhao, Yingjie Chen, et al.. (2023). The interaction between the major vault protein rs4788186 polymorphism, alcohol dependence, and depression among male Chinese problem drinkers. Frontiers in Psychiatry. 14. 1111712–1111712. 2 indexed citations
6.
Fan, Zhichao, Xuebo Pan, Liangcai Zhao, et al.. (2022). Crosstalk of FGFR1 signaling and choline metabolism promotes cell proliferation and survival in prostate cancer cells. International Journal of Cancer. 150(9). 1525–1536. 6 indexed citations
7.
Li, Santie, Zhongxin Zhu, Mei Xue, et al.. (2021). The protective effects of fibroblast growth factor 10 against hepatic ischemia-reperfusion injury in mice. Redox Biology. 40. 101859–101859. 43 indexed citations
8.
Pan, Xuebo, Yihui Shao, Fan Wu, et al.. (2018). FGF21 Prevents Angiotensin II-Induced Hypertension and Vascular Dysfunction by Activation of ACE2/Angiotensin-(1–7) Axis in Mice. Cell Metabolism. 27(6). 1323–1337.e5. 128 indexed citations
9.
Zhang, Yi, et al.. (2018). FGF21 mediates the protective effect of fenofibrate against acetaminophen -induced hepatotoxicity via activating autophagy in mice. Biochemical and Biophysical Research Communications. 503(2). 474–481. 14 indexed citations
10.
Xu, Jianzhong, et al.. (2017). [The clinicopathological characteristics of diabetic nephropathy and non-diabetic renal diseases in diabetic patients].. PubMed. 56(12). 924–929. 8 indexed citations
11.
Wang, Hong, Yihui Shao, Saisai Zhang, et al.. (2017). CXCL16 deficiency attenuates acetaminophen-induced hepatotoxicity through decreasing hepatic oxidative stress and inflammation in mice. Acta Biochimica et Biophysica Sinica. 49(6). 541–549. 22 indexed citations
12.
Zhang, Saisai, Wei Zhang, Yihui Shao, et al.. (2017). Hepatic CXCL16 is increased in gallstone accompanied with liver injury. European Journal of Clinical Investigation. 47(9). 667–674. 8 indexed citations
13.
14.
Park, Yoon Jeong, Xuebo Pan, Kyung Cheul Shin, et al.. (2015). Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance. Nature Communications. 6(1). 7585–7585. 172 indexed citations
15.
Lin, Zhuofeng, Fan Wu, Shaoqiang Lin, et al.. (2014). Adiponectin protects against acetaminophen-induced mitochondrial dysfunction and acute liver injury by promoting autophagy in mice. Journal of Hepatology. 61(4). 825–831. 108 indexed citations
16.
Wu, Fan, Leigang Jin, Tingting Lu, et al.. (2014). Serum CXCL16 as a Novel Marker of Renal Injury in Type 2 Diabetes Mellitus. PLoS ONE. 9(1). e87786–e87786. 30 indexed citations
17.
18.
Lin, Zhuofeng, Qiyong Gong, Chaoming Wu, et al.. (2012). Dynamic Change of Serum FGF21 Levels in Response to Glucose Challenge in Human. The Journal of Clinical Endocrinology & Metabolism. 97(7). E1224–E1228. 50 indexed citations
19.
Gong, Qiyong, Fan Wu, Xuebo Pan, et al.. (2012). Soluble C-X-C chemokine ligand 16 levels are increased in gout patients. Clinical Biochemistry. 45(16-17). 1368–1373. 10 indexed citations
20.
Lin, Zhuofeng, Qiyong Gong, Zhihong Zhou, et al.. (2011). Increased plasma CXCL16 levels in patients with chronic kidney diseases. European Journal of Clinical Investigation. 41(8). 836–845. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos M. Rodríguez‐Ortigosa Breakdown of academic impact, for papers by Misaki Iwashita Breakdown of academic impact, for papers by Ute Haas Breakdown of academic impact, for papers by Zhengzhe Li Breakdown of academic impact, for papers by Yiwen Li Breakdown of academic impact, for papers by Hailing Li Breakdown of academic impact, for papers by Zhen Sun Breakdown of academic impact, for papers by Xiaogang Du Breakdown of academic impact, for papers by Dhanunjay Mukhi Breakdown of academic impact, for papers by Hélène L. Kammoun
Rankless by CCL
2026